Next Article in Journal
Towards the Pharmacological Validation and Phytochemical Profiling of the Decoction and Maceration of Bruguiera gymnorhiza (L.) Lam.—A Traditionally Used Medicinal Halophyte
Next Article in Special Issue
Synthesis and Applications of Nitrogen-Containing Heterocycles as Antiviral Agents
Previous Article in Journal
Drug Solubility Correlation Using the Jouyban–Acree Model: Effects of Concentration Units and Error Criteria
Previous Article in Special Issue
Synthesis of Benzo[4,5]thiazolo[2,3-c][1,2,4]triazole Derivatives via C-H Bond Functionalization of Disulfide Intermediates
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Molecules
Volume 27
Issue 6
10.3390/molecules27061999
molecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

General Method of Synthesis of 5-(Het)arylamino-1,2,3-triazoles via Buchwald–Hartwig Reaction of 5-Amino- or 5-Halo-1,2,3-triazoles

by
Pavel S. Gribanov
1,*,
Anna N. Philippova
1,
Maxim A. Topchiy
2,
Lidiya I. Minaeva
2,
Andrey F. Asachenko
2 and
Sergey N. Osipov
1
1
A. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, 28 Vavilova Str., 119991 Moscow, Russia
2
A.V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences, Leninskiy Prospect 29, 119991 Moscow, Russia
*
Author to whom correspondence should be addressed.
Molecules 2022, 27(6), 1999; https://doi.org/10.3390/molecules27061999
Submission received: 28 February 2022 / Revised: 17 March 2022 / Accepted: 18 March 2022 / Published: 20 March 2022
(This article belongs to the Special Issue Synthesis of Heteroaromatic Compounds)
Browse Figures
Versions Notes

Abstract

:
An efficient access to the novel 5-(het)arylamino-1,2,3-triazole derivatives has been developed. The method is based on Buchwald–Hartwig cross-coupling reaction of 5-Amino or 5-Halo-1,2,3-triazoles with (het)aryl halides and amines, respectively. As result, it was found that palladium complex [(THP-Dipp)Pd(cinn)Cl] bearing expanded-ring N-heterocyclic carbene ligand is the most active catalyst for the process to afford the target molecules in high yields.

1. Introduction

Nitrogen containing heterocycles, in particular five-membered azole systems, are common structural elements of many natural and synthetic biological active compounds. They serve as universal scaffolds for creating new organic molecules with set properties especially for the needs of biomolecular and medicinal chemistry as well as for materials science [1,2,3,4,5,6]. In the last few decades fully substituted and variously functionalized 1,2,3-triazoles, whose structure fragment is not found in nature, became one of the most interesting and widely used class of compounds due to their unique physicochemical properties and synthetic accessibility [7,8]. These compounds possess remarkable thermal and metabolic stability, large dipole moment, and capability for H-bond formation making them effective peptide bond isosteres [9,10,11] that result in a variety of applications in diverse fields of chemistry [12,13,14,15,16,17,18,19,20]. Among fully substituted 1,2,3-triazoles special attention is focused on 5-amino-1,2,3-triazoles and their 5-arylamino derivatives, which exhibit very promising biological properties such as antiviral, antifungal, antiproliferative and antimetastatic activities. They also serve as activators of potassium channel andchelating agents and have a potential for treating inflammatory kidney diseases (Figure 1) [21,22,23,24,25,26].
Since the pioneering Dimroth works published in the beginning of the 20th century [27,28], keteniminate-mediated 1,3-dipolar cycloaddition (DCR) of organic azides with nitriles bearing an active methylene group provide one of the most efficient and straightforward methods to access to the 5-amino-1,2,3-triazole synthesis up to date (Scheme 1) [29,30,31,32].
Unfortunately this approach is not applicable to 5-amino substituted 1,2,3-triazoles including 5-arylamino derivatives. The scope of the existing methods for the synthesis of these compounds is limited to a few examples and has a number of disadvantages. Thus, previously described methods for the preparation of 5-arylamino-1,2,3-triazoles include: (1) interaction between hard accessible carbodiimides and diazo compounds [21]; (2) three-component amine/enolizible ketone/azide reaction leading to low yields of the target products [33]; (3) high temperature thermolysis of the 5-triazenyl-1,2,3-triazoles to give a large amount of 2H-1,2,3-triazole as a by-product [34]; (4) base-mediated hydrolysis of 1,2,3-triazolo[1,5-a]quinazolin-5(4H)-ones [35] as well as Rh-catalyzed azide-alkyne cycloaddition of internal ynamides to afford N,N-disubstituted amino-1,2,3-triazoles [26].
On the other hand, in the past 30 years, palladium-catalyzed cross-coupling reactions leading to the formation of new C-N bonds have become a widely used tool both in academia and in industry [36,37]. This Buchwald–Hartwig amination is the most popular cross-coupling reaction [38,39,40] (Figure 2) to access a wide range of N-mono- and N,N-disubstituted arylamines [41]. Despite impressive advances in the field, coupling of heteroaromatic amines with (het)aryl halides still remains problematic, often requiring long reaction times and time-consuming searches for optimal conditions and catalytic systems [3,42,43,44,45]. tThere are no examples of Buchwald–Hartwig cross-coupling of 5-halo- and 5-amino-1,2,3-triazoles with (het)aryl amines and halides, respectively, to afford N-aryl amino derivatives except a report on synthesis of related 4-amino-1,2,3-triazoles (with just 3 examples) [46].
Therefore, taking into account the growing popularity of 5-amino-1,2,3-triazole derivatives in medical chemistry, the development of new efficient and robust approaches to their synthesis remains of great interest.
We have recently developed effective methods for obtaining 5-amino- [47] and 5-halo-1,2,3-triazoles [48] via one pot azide-nitrile cycloaddition/Dimroth rearrangement (Scheme 2a) and Cu(I)-catalyzed [3+2] cycloaddition reaction of Cu(I)-acetylide and aryl azides with subsequent Cu-triazolide halogenation (Scheme 2b). Based on our experience in Pd-catalyzed cross-couplings of hetaryl halides [49,50,51,52] and halo-1,2,3-triazoles [53,54] we would like to provide details of an efficient route to N-arylamino-1,2,3- triazoles using the Buchwald–Hartwig reaction of 5-amino or 5-halo-1,2,3-triazoles (Scheme 2c).

2. Results and Discussion

We commenced our investigation with the reaction between 1-benzyl-4-phenyl-1,2,3-triazole-5-amine and 1-bromo-4-methylbenzene to screen for optimal conditions for the cross-coupling (Table 1). A series of palladium complexes with expanded-ring NHC ligands (Figure 3) were initially tested as they proved to be competent catalysts for Buchwald–Hartwig amination of (het)aryl halides with primary aryl amines [50,51]. We found that the reaction performed in the presence of 1.0 mol% (THP-Dipp)Pd(cinn)Cl and 1.2 equiv. of sodium tert-butoxide in 1,4-dioxane at 120 °C for 24 h yielded the desired 5-(p-tolyl)amino-1,2,3-triazole 2a in 53% yield (Table 1, entry 1). The reaction did not reveal the full conversion of the starting materials (TLC and 1H NMR analysis). The prolonged reaction time did not result in a better yield of the product. The increase of the Pd-catalyst loading up to 2 mol% and the base up to 3.0 equiv. almost led to quantitative formation of 2a (entry 3). Other NHC-Pd complexes with allyl and metallyl ligands exhibited slightly less activity under tested conditions (entries 4, 5). The traditional Pd(OAc)2/phosphine-based catalytic systems [55] were also tested, exhibiting insufficient activity for the process (entries 6–9).
With these optimized conditions in hand, different 5-amino-1,2,3-triazoles were involved in the Buchwald–Hartwig cross-coupling reactions with a wide range of aromatic and heteroaromatic halides bearing various substituents in their structures. As a result, we found that in all studied cases the nature and location of the substituent in the (het)aryl core of both triazole and halide substrates doesn’t not significantly influence the reaction leading to the formation of the corresponding 5-amino-1,2,3-triazoles derivatives 2a–p including sterically hindered ortho-Me aryl derivatives 2b, 2f, 2j in good and excellent yields. It is noteworthy that the reaction works perfectly for both (het)aryl bromides and chlorides (Scheme 3).
Then, we studied the reversed variant of the Buchwald–Hartwig cross-coupling reaction, namely the interaction of 5-halo-1,2,3-triazoles with aryl amines. Fortunately, we found that the conditions for aminotriazole—aryl halide coupling proved to also be suitable for the combination of halotriazole—aryl amine. Thus, corresponding derivatives of 5-arylamino-1,2,3-triazole such as N-(p-tolylamino) (2a, 2q) and N-(2,4-dimethylamino) (2r) triazoles were obtained in good to excellent yields. Arylamines with electron-withdrawing CF3 group(s) in aromatic ring (2s and 2t) can also be successfully used for this reaction. Example 2u demonstrates that the method is also applicable for the preparation of 4-(N-arylamino)-1,2,3-triazoles from the corresponding 4-halo-1,2,3-triazoles, while their synthesis was previously described via coupling of 4-amino-1,2,3-triazoles [46] (Scheme 4).

3. Materials and Methods

3.1. General Information

All the reactions were carried out under argon atmosphere, and the solvents were distilled from appropriate drying agents prior to use. All reagents were used as purchased from Sigma-Aldrich (Munich, Germany). In the study, 1,4-disubstituted-5-chloro- [48] and 5-amino-1,2,3-triazoles [47] and 1-benzyl-4-bromo-5-methyl-1H-1,2,3-triazole [56] were synthesized according to published procedures. (THP-Dipp)Pd(cinn)Cl [57], (THP-Dipp)Pd(allyl)Cl [58] and (THP-Dipp)Pd(metallyl)Cl were synthesized according to published procedure [57] from corresponding NHC-silver (I) complexes. Analytical data was in accordance with the literature data. Analytical TLC was performed with Merck silica gel 60 F 254 plates (Darmstadt, Germany); visualization was accomplished with UV light or iodine vapors. Chromatography was carried out using Merck silica gel (Kieselgel 60, 0.063–0.200 mm, Darmstadt, Germany) and petroleum ether/ethyl acetate as an eluent. The NMR spectra were obtained with Bruker AV-400, Karlsruhe, Germany) (400 MHz 1H, 101 MHz 13C, 376 MHz 19F) using TMS and CCl3F as references for 1H and 19F NMR spectra. respectively. Chemical shifts for 1H and 13C were reported as δ values (ppm).

3.2. General Procedure for Preparation of N-arylamino-1,2,3-triazoles via BHA Reaction of 5-Amino or 4(5)-halo-1,2,3-triazoles

Under argon in a Schlenk tube with magnetic stirring bar, corresponding amino- or halo-1,2,3-triazole (0. 5 mmol), (het)arylhalide or primary amine (1.0 equiv.) were dissolved in dry 1,4-dioxane (2.5 mL) at room temperature. The solution was degassed with three freeze-pump-thaw cycles. Then 6.6 mg (0.01 mmol, 2 mol%) of (THP-Dipp)Pd(cinn)Cl and sodium tert-butoxide (3.0 equiv.) were added to the reaction mixture, and the reaction mixture was stirred at 120 °C (oil bath temperature) for 18 h. After cooling to room temperature, the reaction mixture was poured into water and extracted with dichloromethane (3 × 10 mL). The combined organic phases were washed with brine, dried over MgSO4, filtered and concentrated under reduced pressure. Purification by chromatography (eluent—hexane: ethyl acetate 4:1) gave analytically pure corresponding N-arylamino-1,2,3-triazole as a white solid.

3.3. Preparation and Characterization of Novel Compounds

(THP-Dipp)Pd(methallyl)Cl
The title compound was synthesized according to literature procedure [58] from (6-Dipp)AgBr and (2-Methylallyl)palladium(II) chloride dimer as a white powder (88% yield). 1H NMR (400 MHz, Acetone-d6) δ 7.40–7.11 (m, 6H), 3.85–3.56 (m, 7H), 3.33–3.18 (m, 2H), 2.88 (s, 1H), 2.67–2.59 (m, 2H), 2.53–2.37 (m, 2H), 1.51–1.15 (m, 24H), 1.02 (s, 2H). 13C DEPTQ-135 NMR (Acetone, 101 MHz): δ 214.8, 146.6, 143.8, 130.0, 129.1, 128.2, 125.5, 70.3, 50.3, 49.2, 47.0, 47.0, 29.1, 27.1, 25.2, 24.9, 22.9, 22.1, 21.2, 21.0. HRMS (ESI): calcd for C32H47N2Pd [(THP-Dipp)Pd(methallyl)]+: 563.2775, 564.2788, 565.2781, 566.2808, 567.2777; found: 563.2776, 564.2795, 565.2788, 566.2810, 567.2780.
1-benzyl-5-(p-tolylamino)-4-phenyl-1H-1,2,3-triazole (2a)
Molecules 27 01999 i002
From 1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine and 1-bromo-4-methylbenzene (165 mg, 97% yield) or from 1-benzyl-5-chloro-4-phenyl-1H-1,2,3-triazole and p-toluidine (163 mg, 96% yield), following general procedure, 2a was obtained as a white solid, m.p. 181–182 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.82 (d, J = 7.0 Hz, 2H), 7.34–7.26 (m, 6H), 7.22–7.17 (m, 2H), 7.00 (d, J = 8.4 Hz, 2H), 6.45 (d, J = 8.4 Hz, 2H), 5.36 (s, 2H), 5.05 (s, 1H), 2.27 (s, 3H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 141.2, 140.9, 134.8, 132.1, 130.3, 130.0, 129.0, 128.7, 128.4, 128.0, 127.9, 126.0, 114.3, 51.4, 20.6. IR (υ/cm−1): 737.34 (VS), 812 (VS), 1006 (S), 1072 (S), 1177 (S), 1251 (S), 1288 (S), 1325 (S), 1359 (S), 1422 (S), 1441 (S), 1518 (S), 1586 (S), 1610 (S), 1810 (M), 1888 (M), 1955 (M), 2980 (W), 3025 (W), 3249 (M). HRMS (ESI): calcd for C22H21N4 [M+H]+: 341.1761; found: 341.1769.
1-benzyl-5-(o-tolylamino)-4-phenyl-1H-1,2,3-triazole (2b)
Molecules 27 01999 i003
From 1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine and 1-bromo-2-methylbenzene, following general procedure, 2b (165 mg, 97% yield) was obtained as a white solid, m.p. 193–195 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.76 (d, J = 7.0 Hz, 2H), 7.33–7.25 (m, 6H), 7.18–7.12 (m, 3H), 6.98 (t, J = 7.5 Hz, 1H), 6.83 (t, J = 7.4 Hz, 1H), 6.25 (d, J = 8.1 Hz, 1H), 5.33 (s, 2H), 4.82 (s, 1H), 2.12 (s, 3H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 141.5, 141.0, 134.7, 131.9, 131.1, 130.4, 129.0, 128.8, 128.5, 128.1, 127.8, 127.6, 125.9, 123.3, 120.7, 112.7, 51.8, 17.5. IR (υ/cm−1): 3271 (W), 1606 (S), 1586 (S), 1571 (S), 1514 (S), 1496 (S), 1448 (S), 1411 (S), 1362 (S), 1294 (S), 1251 (S), 1159 (S), 1110 (S), 1073 (S), 1006 (S), 769 (VS), 747 (VS), 734 (VS), 717 (VS). HRMS (ESI): calcd for C22H21N4 [M+H]+: 341.1761; found: 341.1764.
1-benzyl-5-(phenylamino)-4-phenyl-1H-1,2,3-triazole (2c)
Molecules 27 01999 i004
From 1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine and bromobenzene, following general procedure, 2c (151 mg, 93% yield) was obtained as a white solid, m.p. 187–188 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.80 (dd, J = 8.3, 1.4 Hz, 2H), 7.31–7.24 (m, 6H), 7.20–7.15 (m, 4H), 6.87 (t, J = 7.4 Hz, 1H), 6.52 (d, J = 7.6 Hz, 2H), 5.34 (s, 2H), 5.14 (s, 1H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 143.6, 141.1, 134.7, 131.6, 130.2, 129.9, 129.0, 128.8, 128.5, 128.1, 127.9, 126.0, 120.7, 114.3, 51.5. IR (υ/cm−1): 3234 (M), 3180 (W), 2930 (W), 1602 (S), 1582 (S), 1568 (S), 1496 (S), 1445 (S), 1422 (S), 1364 (S), 1325 (S), 1256 (S), 1236 (S), 1176 (S), 1151 (S), 1077 (S), 770 (VS), 752 (VS). HRMS (ESI): calcd for C21H19N4 [M+H]+: 327.1604; found: 327.1608.
1-benzyl-5-((4-benzonitrile)amino)-4-phenyl-1H-1,2,3-triazole (2d)
Molecules 27 01999 i005
From 1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine and 4-bromobenzonitrile, following general procedure, 2d (172 mg, 98% yield) was obtained as a white solid, m.p. 179–180 °C. 1H NMR (400 MHz, DMSO-d6) δ 9.02 (s, 1H), 7.74 (d, J = 7.9 Hz, 2H), 7.48 (d, J = 8.5 Hz, 2H), 7.37 (t, J = 7.6 Hz, 2H), 7.31–7.24 (m, 4H), 7.19–7.15 (m, 2H), 6.52 (d, J = 8.6 Hz, 2H), 5.45 (s, 2H). 13C{1H} NMR (101 MHz, DMSO-d6) δ 148.5, 139.2, 135.2, 133.8, 130.7, 130.0, 128.8, 128.6, 128.0, 127.9, 127.8, 125.2, 119.6, 113.8, 100.3, 50.2. IR (υ/cm−1): 2962 (M), 2927 (W), 2223 (M), 1604 (S), 1590 (S), 1519 (S), 1456 (S), 1434 (S), 1426 (S), 1358 (S), 1323 (S), 1258 (S), 1173 (S), 1006 (S), 822 (VS), 773 (VS), 734 (VS), 716 (VS), 696 (VS). HRMS (ESI): calcd for C22H18N5 [M+H]+: 352.1557; found: 352.1556.
1-tert-butyl-5-(p-tolylamino)-4-phenyl-1H-1,2,3-triazole (2e)
Molecules 27 01999 i006
From 1-tert-butyl-4-phenyl-1H-1,2,3-triazol-5-amine and 1-bromo-4-methylbenzene, following general procedure, 2e (100 mg, 65% yield) was obtained as a white solid, m.p. 241–242 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.80–7.74 (m, 2H), 7.28–7.20 (m, 3H), 6.97 (d, J = 6.5 Hz, 2H), 6.46 (d, J = 6.1 Hz, 2H), 5.25 (s, 1H), 2.22 (s, 3H), 1.68 (s, 9H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 142.6, 142.3, 131.8, 130.6, 130.3, 129.3, 128.6, 127.8, 126.1, 114.2, 61.3, 29.8, 20.6. IR (υ/cm−1): 3233 (M), 2975 (M), 1612 (S), 1593 (S), 1568 (S), 1516 (VS), 1449 (S), 1410 (S), 1371 (S), 1309 (VS), 1235 (S), 1195 (S), 991 (VS), 805 (VS), 762 (VS), 693 (VS). HRMS (ESI): calcd for C19H23N4 [M+H]+: 307.1917; found: 307.1921.
1-benzyl-5-((4-fluoro-2-methylphenyl)amino)-4-phenyl-1H-1,2,3-triazole (2f)
Molecules 27 01999 i007
From 1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine and 1-bromo-4-fluoro- 2-methylbenzene, following general procedure, 2f (177 mg, >99% yield) was obtained as a white solid, m.p. 216–217 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.74 (dd, J = 8.2, 1.2 Hz, 2H), 7.33 (t, J = 7.3 Hz, 2H), 7.31–7.27 (m, 4H), 7.16–7.12 (m, 2H), 6.90 (dd, J = 9.1, 2.7 Hz, 1H), 6.70–6.60 (m, 1H), 6.15 (dd, J = 8.7, 4.8 Hz, 1H), 5.35 (s, 2H), 4.74 (s, 1H), 2.12 (s, 3H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 157.4 (d, J = 239.0 Hz), 140.7, 137.5 (d, J = 2.0 Hz), 134.6, 132.1, 130.4, 129.0, 128.9, 128.6, 128.2, 127.8, 125.9, 125.4 (d, J = 7.6 Hz), 117.8 (d, J = 22.8 Hz), 114.1 (d, J = 8.2 Hz), 113.6 (d, J = 22.3 Hz), 51.8, 17.6. 19F NMR (376 MHz, Chloroform-d) δ -123.92. IR (υ/cm−1): 3241 (W), 1610 (S), 1588 (S), 1516 (S), 1498 (S), 1446 (S), 1411 (S), 1362 (S), 1268 (S), 1239 (S), 1199 (S), 1007 (S), 953 (S), 856 (VS), 800 (VS), 771 (VS), 737 (VS), 714 (VS), 697 (VS). HRMS (ESI): calcd for C22H20FN4 [M+H]+: 359.1667; found: 359.1670.
1-tert-butyl-5-(phenylamino)-4-phenyl-1H-1,2,3-triazole (2g)
Molecules 27 01999 i008
From 1-tert-butyl-4-phenyl-1H-1,2,3-triazol-5-amine and bromobenzene, following general procedure, 2g (136 mg, 93% yield) was obtained as a white solid, m.p. 228–229 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.76 (d, J = 7.3 Hz, 2H), 7.25–7.19 (m, 3H), 7.16 (t, J = 7.1 Hz, 2H), 6.81 (t, J = 7.3 Hz, 1H), 6.55 (d, J = 7.6 Hz, 2H), 5.58 (s, 1H), 1.68 (s, 9H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 144.6, 142.5, 131.6, 130.2, 129.7, 128.6, 127.9, 126.2, 120.1, 114.1, 61.5, 29.8. IR (υ/cm−1): 3346 (W), 3056 (W), 2980 (W), 2931 (W), 1604 (S), 1566 (S), 1498 (S), 1423 (S), 1370 (S), 1309 (S), 1233 (S), 1183 (S), 990 (VS), 768 (VS), 746 (VS), 717 (VS), 690 (VS). HRMS (ESI): calcd for C18H21N4 [M+H]+: 293.1761; found: 293.1766.
1-benzyl-5-((pyridine-2-yl)amino)-4-phenyl-1H-1,2,3-triazole (2h)
Molecules 27 01999 i009
From 1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine and 2-bromopyridine, following general procedure, (2h) (127 mg, 77% yield) was obtained as a white solid, m.p. 173–174 °C. 1H NMR (400 MHz, DMSO-d6) δ 8.93 (s, 1H), 7.99–7.96 (m, 1H), 7.77 (d, J = 7.0 Hz, 2H), 7.57–7.52 (m, 1H), 7.37 (t, J = 7.5 Hz, 2H), 7.32–7.25 (m, 4H), 7.19 (dd, J = 7.6, 1.8 Hz, 2H), 6.76–6.72 (m, 1H), 6.62 (d, J = 8.5 Hz, 1H), 5.40 (s, 2H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 156.1, 148.0, 141.2, 138.6, 134.6, 130.4, 130.2, 128.8, 128.7, 128.4, 128.2, 128.1, 125.9, 115.9, 107.1, 51.6. IR (υ/cm−1): 3140 (W), 3082 (W), 3062 (W), 2914 (M), 2856 (M), 1588 (S), 1522 (S), 1500 (S), 1436 (S), 1361 (S), 1319 (S), 1233 (S), 1213 (S), 1153 (VS), 1101 (S), 1074 (S), 996 (VS), 783 (VS), 772 (VS), 738 (VS). HRMS (ESI): calcd for C20H18N5 [M+H]+: 328.1557; found: 328.1561.
1-benzyl-5-((4-tert-butylphenyl))amino)-4-phenyl-1H-1,2,3-triazole (2i)
Molecules 27 01999 i010
From 1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine and 1-bromo-4-tert-butylbenzene, following general procedure, 2i (172 mg, 90% yield) was obtained as a white solid, m.p. 169–171 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.81 (d, J = 7.0 Hz, 2H), 7.31–7.24 (m, 6H), 7.19–7.14 (m, 4H), 6.46 (d, J = 8.7 Hz, 2H), 5.33 (s, 2H), 5.07 (s, 1H), 1.27 (s, 9H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 143.6, 141.0, 141.0, 134.8, 132.1, 130.4, 128.9, 128.8, 128.4, 128.0, 127.9, 126.6, 126.0, 114.1, 51.4, 34.2, 31.6. IR (υ/cm−1): 3253 (M), 3054 (M), 3034 (M), 2956 (M), 2900 (M), 2857 (M), 1607 (S), 1587 (S), 1568 (S), 1515 (VS), 1400 (S), 1360 (S), 1252 (S), 1190 (S), 922 (S), 814 (S), 770 (VS), 737 (VS), 719 (VS), 695 (VS). HRMS (ESI): calcd for C25H27N4 [M+H]+: 383.2230; found: 383.2241.
1-benzyl-5-(mesitylamino)-4-phenyl-1H-1,2,3-triazole (2j)
Molecules 27 01999 i011
From 1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine and 2-bromo- 1,3,5-trimethylbenzene, following general procedure, 2j (146 mg, 79% yield) was obtained as a white solid, m.p. 132–133 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.71 (d, J = 7.3 Hz, 2H), 7.31–7.20 (m, 6H), 6.89 (dd, J = 7.2, 2.2 Hz, 2H), 6.72 (s, 2H), 5.15 (s, 2H), 4.93 (s, 1H), 2.23 (s, 3H), 1.75 (s, 6H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 135.8, 135.1, 134.9, 134.9, 133.6, 131.2, 130.1, 129.8, 128.8, 128.4, 128.2, 127.2, 127.1, 126.2, 51.6, 20.7, 18.2. IR (υ/cm−1): 3339 (M), 3060 (W), 3032 (M), 2913 (M), 2853 (W), 1606 (S), 1586 (S), 1571 (S), 1485 (S), 1445 (S), 1421 (S), 1361 (S), 1317 (S), 1250 (S), 1073 (S), 1029 (S), 994 (S), 840 (S), 769 (VS), 724 (VS), 694 (VS). HRMS (ESI): calcd for C24H25N4 [M+H]+: 369.2074; found: 369.2074.
1-tert-butyl-5-((pyridine-3-yl)amino)-4-phenyl-1H-1,2,3-triazole (2k)
Molecules 27 01999 i012
From 1-tert-butyl-4-phenyl-1H-1,2,3-triazol-5-amine and 3-chloropyridine, following general procedure, 2k (110 mg, 75% yield) was obtained as a white solid, m.p. 233–234 °C. 1H NMR (400 MHz, DMSO-d6) δ 8.27 (s, 1H), 7.94 (s, 1H), 7.90 (d, J = 4.7 Hz, 1H), 7.73 (d, J = 7.9 Hz, 2H), 7.32 (t, J = 7.6 Hz, 2H), 7.24 (t, J = 7.6 Hz, 1H), 7.08 (dd, J = 8.3, 4.6 Hz, 1H), 6.73 (d, J = 8.0 Hz, 1H), 1.65 (s, 9H). 13C{1H} NMR (101 MHz, DMSO-d6) δ 141.6, 140.9, 139.9, 136.0, 131.1, 130.3, 128.6, 127.8, 125.4, 124.0, 119.5, 60.7, 29.1. IR (υ/cm−1): 3252 (W), 3002 (W), 2974 (W), 1589 (S), 1580 (S), 1508 (S), 1477 (S), 1449 (S), 1370 (S), 1299 (S), 1239 (S), 990 (VS), 800 (VS), 772 (VS), 709 (VS). HRMS (ESI) calcd for C17H20N5 [M+H]+: 294.1719; found: 294.1718.
1-phenethyl-5-((pyridine-3-yl)amino)-4-phenyl-1H-1,2,3-triazole (2l)
Molecules 27 01999 i013
From 1-phenethyl-4-phenyl-1H-1,2,3-triazol-5-amine and 3-chloropyridine, following general procedure, 2l (142 mg, 83% yield) was obtained as a white solid, m.p. 199–200 °C. 1H NMR (400 MHz, DMSO-d6) δ 8.46 (s, 1H), 8.01–7.92 (m, 2H), 7.72 (d, J = 7.3 Hz, 2H), 7.35 (t, J = 7.4 Hz, 2H), 7.29–7.16 (m, 4H), 7.12 (d, J = 7.2 Hz, 2H), 7.07 (dd, J = 8.0, 4.6 Hz, 1H), 6.65 (dd, J = 8.5, 1.3 Hz, 1H), 4.44 (t, J = 7.3 Hz, 2H), 3.13 (t, J = 7.6 Hz, 2H). 13C{1H} NMR (101 MHz, DMSO-d6) δ 140.6, 140.3, 138.3, 137.5, 136.4, 131.5, 130.3, 128.7, 128.6, 128.5, 127.7, 126.6, 125.2, 124.0, 119.7, 47.7, 35.0. IR (υ/cm−1): 3203 (W), 3162 (W), 3083 (W), 3025 (W), 2969 (W), 1582 (S), 1569 (S), 1480 (S), 1455 (S), 1402 (S), 1361 (S), 1312 (S), 1278 (S), 1232 (S), 990 (S), 799 VS, 763 (VS), 743 (VS), 701 (VS). HRMS (ESI): calcd for C21H20N5 [M+H]+: 342.1719; found: 342.1717.
1-benzyl-5-((3,5-dimethylphenyl)amino)-4-phenyl-1H-1,2,3-triazole (2m)
Molecules 27 01999 i014
From 1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine and 1-bromo- 3,5-dimethylbenzene, following general procedure, 2m (149 mg, 84% yield) was obtained as a white solid, m.p. 154–155 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.82 (d, J = 7.0 Hz, 2H), 7.35–7.26 (m, 6H), 7.23–7.19 (m, 2H), 6.54 (s, 1H), 6.15 (s, 2H), 5.34 (s, 2H), 5.06 (s, 1H), 2.18 (s, 6H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 143.7, 141.1, 139.7, 134.8, 131.9, 130.4, 128.9, 128.8, 128.4, 128.1, 128.0, 126.0, 122.7, 112.2, 51.4, 21.5. IR (υ/cm−1): 3266 (W), 2919 (W), 1601 (S), 1585 (S), 1495 (S), 1444 (S), 1353 (S), 1324 (S), 1233 (S), 1170 (S), 1004 (VS), 993 (VS), 837 (VS), 774 (VS), 739 (VS), 727 (VS), 691 (VS). HRMS (ESI): calcd for C23H23N4 [M+H]+: 355.1917; found: 355.1920.
1-benzyl-5-((pyrimidine-4-yl)amino)-4-phenyl-1H-1,2,3-triazole (2n)
Molecules 27 01999 i015
From 1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine and 4-chloropyrimidine, following general procedure, 2n (161 mg, 98% yield) was obtained as a white solid, m.p. 156–157 °C. 1H NMR (400 MHz, DMSO-d6) δ 9.40 (s, 1H), 8.10 (s, 1H), 7.93 (d, J = 5.6 Hz, 2H), 7.75 (d, J = 7.7 Hz, 2H), 7.38 (t, J = 7.6 Hz, 2H), 7.27 (q, J = 7.7, 6.7 Hz, 4H), 7.18 (d, J = 7.7 Hz, 2H), 5.44 (s, 2H). 13C{1H} NMR (101 MHz, DMSO-d6) δ 152.5, 141.8, 139.4, 135.3, 135.0, 133.0, 130.5, 130.4, 128.7, 128.5, 127.8, 127.8, 127.8, 125.3, 50.5. IR (υ/cm−1): 3189 (W), 3067 (W), 2953 (W), 1593 (S), 1497 (S), 1472 (S), 1446 (S), 1360 (S), 1318 (S), 1278 (S), 1231 (S), 1150 (S), 996 (S), 825 (VS), 767 (VS), 734 (VS), 694 (VS). HRMS (ESI) calcd for C19H17N6 [M+H]+: 329.1515; found: 329.1514.
1-benzyl-5-((pyridine-3-yl)amino)-4-phenyl-1H-1,2,3-triazole (2o)
Molecules 27 01999 i016
From 1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine and 3-chloropyridine (159 mg, 97% yield) or 3-bromopyridine (163 mg, >99% yield), following general procedure, 2o was obtained as a white solid, m.p. 169–170 °C. 1H NMR (400 MHz, Chloroform-d) δ 8.02–7.97 (m, 2H), 7.73 (dd, J = 7.9, 1.6 Hz, 2H), 7.27–7.22 (m, 3H), 7.21–7.17 (m, 3H), 7.15–7.11 (m, 2H), 6.92 (dd, J = 8.3, 4.7 Hz, 1H), 6.52 (ddd, J = 8.3, 2.7, 1.2 Hz, 1H), 6.30 (s, 1H), 5.36 (s, 2H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 141.3, 141.3, 140.3, 136.9, 134.3, 130.6, 129.9, 129.0, 128.8, 128.6, 128.4, 127.9, 125.9, 124.1, 120.3, 51.6. IR (υ/cm−1): 3221 (W), 3173 (M), 3090 (W), 3043 (M), 3027 (M), 2962 (M), 2904 (M), 2780 (M), 1608 (S), 1583 (S), 1570 (S), 1538 (S), 1480 (S), 1427 (S), 1409 (S), 1364 (S), 1321 (S), 1246 (S), 1234 (S), 1048 (S), 1006 (S), 994 (S). HRMS (ESI): calcd for C20H18N5 [M+H]+: 328.1557; found: 328.1561.
N4,N6-bis(1-benzyl-4-phenyl-1H-1,2,3-triazol-5-yl)pyrimidine-4,6-diamine (2p)
Molecules 27 01999 i017
From 1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine and 4,6-dichloropyrimidine, following general procedure, 2p (88 mg, 61% yield) was obtained as a white solid, m.p. 263–264 °C. 1H NMR (400 MHz, DMSO-d6) δ 9.28 (s, 2H), 7.98 (s, 1H), 7.73 (s, 4H), 7.40 (s, 4H), 7.37–7.29 (m, 3H), 7.28–7.10 (m, 10H), 5.38 (s, 4H). 13C{1H} NMR (101 MHz, DMSO-d6) δ 161.3, 158.2, 139.4, 135.2, 130.2, 130.1, 128.7, 128.5, 127.9, 127.8, 125.3, 50.5. IR (υ/cm−1): 3064 (M), 3032 (M), 2927 (M), 1601 (S), 1587 (S), 1496 (S), 1356 (S), 1288 (S), 1237 (S), 1188 (S), 1073 (S), 991 (S), 822 (VS), 769 (VS), 734 (VS), 720 (VS), 692 (VS). HRMS (ESI): calcd for C34H29N10 [M+H]+: 577.2571; found: 577.2574.
1-phenethyl-5-(p-tolylamino)-4-phenyl- 1H-1,2,3-triazole (2q)
Molecules 27 01999 i018
From 5-chloro-1-phenethyl-4-phenyl-1H-1,2,3-triazole and p-toluidine, following general procedure, 2q (147 mg, 83% yield) was obtained as a white solid, m.p. 152–153 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.74 (d, J = 7.9 Hz, 2H), 7.30–7.23 (m, 6H), 7.04–6.99 (m, 2H), 6.93 (d, J = 8.0 Hz, 2H), 6.29 (d, J = 7.5 Hz, 2H), 4.77 (s, 1H), 4.37 (t, J = 8.3 Hz, 2H), 3.14 (t, J = 8.4 Hz, 2H), 2.21 (s, 3H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 140.8, 139.5, 137.6, 132.9, 130.2, 129.9, 129.1, 129.0, 128.7, 128.4, 127.3, 126.2, 125.9, 114.2, 49.2, 36.4, 20.6. IR (υ/cm−1): 3205 (M), 3176 (M), 3085 (M), 3027 (M), 2950 (M), 2931 (M), 1878 (M), 1610 (S), 1585 (S), 1572 (S), 1520 (S), 1498 (S), 1451 (S), 1364 (S), 1258 (S), 1011 (S), 807 (VS), 762 (VS), 748 (VS), 699 (VS). HRMS (ESI): calcd for C23H23N4 [M+H]+: 355.1917; found: 355.1920.
1-benzyl-5-((2,4-dimethylphenyl)amino)-4-phenyl-1H-1,2,3-triazole (2r)
Molecules 27 01999 i019
From 1-benzyl-5-chloro-4-phenyl-1H-1,2,3-triazole and 2,4-dimethylaniline, following general procedure, 2r (169 mg, 95% yield) was obtained as a white solid, m.p. 194–195 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.77 (d, J = 7.5 Hz, 2H), 7.33–7.24 (m, 6H), 7.16–7.11 (m, 2H), 6.99 (s, 1H), 6.78 (d, J = 8.2 Hz, 1H), 6.16 (d, J = 8.1 Hz, 1H), 5.31 (s, 2H), 4.84 (s, 1H), 2.25 (s, 3H), 2.11 (s, 3H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 140.5, 139.0, 134.7, 132.5, 131.8, 130.2, 130.1, 129.0, 128.8, 128.5, 128.1, 127.9, 127.9, 126.0, 123.5, 113.0, 51.8, 20.6, 17.5. IR (υ/cm−1): 3260 (W), 2962 (W), 2924 (W), 2857 (W), 1608 (S), 1587 (S), 1571 (S), 1517 (S), 1446 (S), 1360 (S), 1237 (S), 1156 (S), 804 (VS), 766 (VS), 736 (VS), 694 (VS). HRMS (ESI): calcd for C23H23N4 [M+H]+: 355.1917; found: 355.1918.
1-benzyl-5-((3-(trifluoromethyl)phenyl)amino)-4-phenyl-1H-1,2,3-triazole (2s)
Molecules 27 01999 i020
From 1-benzyl-5-chloro-4-phenyl-1H-1,2,3-triazole and 3-(trifluoromethyl)aniline, following general procedure, 2s (159 mg, 81% yield) was obtained as a white solid, m.p. 115–117 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.72 (dd, J = 6.4, 2.9 Hz, 2H), 7.23–7.11 (m, 9H), 7.05 (d, J = 7.7 Hz, 1H), 6.81 (s, 1H), 6.55 (d, J = 8.0 Hz, 1H), 6.41 (m, 1H), 5.32 (s, 2H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 144.3, 141.3, 134.2, 131.9 (q, J = 32.3 Hz), 131.1, 130.2, 129.8, 128.9, 128.8, 128.5, 128.3, 128.0, 125.9, 124.0 (q, J = 272.8 Hz), 116.9, 110.9 (q, J = 3.6 Hz), 51.5. 19F NMR (376 MHz, Chloroform-d) δ -62.8. IR (υ/cm−1): 3195 (M), 3038 (M), 2927 (M), 1619 (S), 1586 (S), 1571 (S), 1495 (S), 1486 (S), 1444 (S), 1425 (S), 1336 (VS), 1231 (S), 1163 (VS), 1118 (VS), 1099 (S), 1067 (VS), 1006 (S), 996 (S), 916 (S), 871 (S), 791 (S), 769 (VS), 736 (VS), 692 (VS). HRMS (ESI): calcd for C22H18F3N4 [M+H]+: 395.1478; found: 395.1482.
1-benzyl-5-((3,5-bis(trifluoromethyl)phenyl)amino)-4-phenyl-1H-1,2,3-triazole (2t)
Molecules 27 01999 i021
From 1-benzyl-5-chloro-4-phenyl-1H-1,2,3-triazole and 3,5-bis(trifluoromethyl) aniline, following general procedure, 2t (136 mg, 59% yield) was obtained as a white solid, m.p. 110–111 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.70 (dd, J = 7.7, 1.9 Hz, 2H), 7.35–7.26 (m, 4H), 7.24–7.22 (m, 3H), 7.16–7.11 (m, 2H), 6.75 (s, 2H), 5.52 (s, 1H), 5.42 (s, 2H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 144.8, 141.9, 133.8, 133.0 (q, J = 33.5 Hz), 129.8, 129.5, 129.2, 129.0, 128.8, 128.7, 127.9, 126.0, 125.8, 123.1 (q, J = 272.6 Hz), 113.8 (p, J = 3.8 Hz), 113.7, 113.6, 52.0. 19F NMR (376 MHz, Chloroform-d) δ -63.19. IR (υ/cm−1): 3457 (W), 3204 (W), 3074 (W), 2930 (W), 1616 (S), 1590 (S), 1498 (S), 1471 (S), 1387 (S), 1276 (S), 1182 (S), 1130 (VS), 953 (VS), 873 (VS), 766 (VS), 700 (VS). HRMS (nESI): calcd for C23H17F6N4 [M+H]+: 463.1357; found: 463.1348.
1-benzyl-4-(p-tolylamino)-5-methyl-1H-1,2,3-triazole (2u)
Molecules 27 01999 i022
From 1-benzyl-4-bromo-5-methyl-1H-1,2,3-triazole and p-toluidine, following general procedure, 2u (97 mg, 69% yield) was obtained as a white solid, m.p. 133–134 °C. 1H NMR (400 MHz, Chloroform-d) δ 7.38–7.32 (m, 3H), 7.19 (d, J = 6.7 Hz, 2H), 6.98 (d, J = 8.3 Hz, 2H), 6.63 (d, J = 8.1 Hz, 2H), 5.61 (s, 1H), 5.48 (s, 2H), 2.24 (s, 3H), 2.02 (s, 3H). 13C{1H} NMR (101 MHz, Chloroform-d) δ 144.7, 142.4, 134.6, 129.8, 129.2, 129.1, 128.5, 127.3, 125.1, 114.8, 52.9, 29.8, 20.6. IR (υ/cm−1): 3246 (M), 3109 (W), 3034 (M), 2924 (M), 2855 (M), 1884 (M), 1602 (S), 1511 (S), 1455 (S), 1435 (S), 1390 (S), 1345 (S), 1234 (S), 1121 (S), 815 (VS), 725 (VS), 696 (VS). HRMS (ESI): calcd for C17H18N5 [M+H]+: 279.1604; found: 279.1606.

4. Conclusions

In conclusion, we have developed an efficient and robust method for the preparation of a series of new 5-(het)arylamino-1,2,3-triazole derivatives via Buchwald–Hartwig cross-coupling reaction of 5-amino or 5-halo-1,2,3-triazoles with (het)aryl halides and amines respectively. As a result of the careful screening for optimal conditions, a catalytic system based on the palladium complex [(THP-Dipp)Pd(cinn)Cl] with expanded-ring NHC ligand has been revealed as the most active for the process. The reaction functions perfectly in 1,4-dioxane medium at 120 °C in the presence of an excess of t-BuONa to afford a variety of 5-(het)arylamino-1,2,3-triazoles with good to excellent yields. The compounds obtained have major potential to be used in biomolecular chemistry and material science.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/molecules27061999/s1, copies of 1H and 13C NMR spectra for all novel compounds.

Author Contributions

Conceptualization, P.S.G., A.F.A., S.N.O.; methodology, P.S.G.; investigation, P.S.G. (synthesis, NMR spectra registering and characterization), A.N.P. (synthesis), A.F.A., L.I.M., M.A.T. (synthesis of (THP-Dipp)Pd(allyl)Cl and (THP-Dipp)PdMetallylCl complexes); writing—original draft preparation, P.S.G., S.N.O.; writing—review and editing, P.S.G., S.N.O.; supervision, P.S.G.; project administration, P.S.G.; funding acquisition, P.S.G. All authors have read and agreed to the published version of the manuscript.

Funding

This work was financially supported by the Russian Science Foundation (grant RSF No. 20-73-00291).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Data are contained within the article and Supplementary Materials.

Acknowledgments

NMR studies and spectral characterization were performed with financial support from the Ministry of Science and Higher Education of the Russian Federation using the equipment of the Center for Molecular Composition Studies of INEOS RAS. Part of this work (synthesis of (THP-Dipp)Pd(allyl)Cl and (THP-Dipp)Pd(methallyl)Cl complexes) was carried out as a part of the State Program of A. V. Topchiev Institute of Petrochemical Synthesis of the Russian Academy of Sciences (TIPS RAS).

Conflicts of Interest

The authors declare no conflict of interest.

Sample Availability

Samples of all of the compounds are available from the authors.

References

  1. Thansandote, P.; Lautens, M. Construction of nitrogen-containing heterocycles by C-H bond functionalization. Chem. Eur. J. 2009, 15, 5874–5883. [Google Scholar] [CrossRef] [PubMed]
  2. Chen, D.; Su, S.-J.; Cao, Y. Nitrogen heterocycle-containing materials for highly efficient phosphorescent OLEDs with low operating voltage. J. Mater. Chem. C 2014, 2, 9565–9578. [Google Scholar] [CrossRef]
  3. Huang, W.; Buchwald, S.L. Palladium-Catalyzed N-Arylation of Iminodibenzyls and Iminostilbenes with Aryl- and Heteroaryl Halides. Chem. Eur. J. 2016, 22, 14186–14189. [Google Scholar] [CrossRef] [PubMed]
  4. Bikker, J.A.; Brooijmans, N.; Wissner, A.; Mansour, T.S. Kinase domain mutations in cancer: Implications for small molecule drug design strategies. J. Med. Chem. 2009, 52, 1493–1509. [Google Scholar] [CrossRef] [PubMed]
  5. Quintas-Cardama, A.; Kantarjian, H.; Cortes, J. Flying under the radar: The new wave of BCR-ABL inhibitors. Nat. Rev. Drug. Discov. 2007, 6, 834–848. [Google Scholar] [CrossRef]
  6. Topchiy, M.A.; Zharkova, D.A.; Asachenko, A.F.; Muzalevskiy, V.M.; Chertkov, V.A.; Nenajdenko, V.G.; Nechaev, M.S. Mild and Regioselective Synthesis of 3-CF3-Pyrazoles by the AgOTf-Catalysed Reaction of CF3-Ynones with Hydrazines. Eur. J. Org. Chem. 2018, 2018, 3750–3755. [Google Scholar] [CrossRef]
  7. Sharma, P.; Kumar, A.V.; Upadhyay, S.; Singh, J.; Sahu, V. A novel approach to the synthesis of 1,2,3-triazoles and their SAR studies. Med. Chem. Res. 2009, 19, 589–602. [Google Scholar] [CrossRef]
  8. Gomes, A.; Martins, P.; Rocha, D.R.; Neves, M.; Ferreira, V.F.; Silva, A.; Cavaleiro, J.; da Silva, F. Consecutive Tandem Cycloaddition between Nitriles and Azides; Synthesis of 5-Amino-1H-[1,2,3]-triazoles. Synlett 2013, 24, 41–44. [Google Scholar] [CrossRef]
  9. Dheer, D.; Singh, V.; Shankar, R. Medicinal attributes of 1,2,3-triazoles: Current developments. Bioorg. Chem. 2017, 71, 30–54. [Google Scholar] [CrossRef]
  10. Bonandi, E.; Christodoulou, M.S.; Fumagalli, G.; Perdicchia, D.; Rastelli, G.; Passarella, D. The 1,2,3-triazole ring as a bioisostere in medicinal chemistry. Drug Discov. Today 2017, 22, 1572–1581. [Google Scholar] [CrossRef]
  11. Lauria, A.; Delisi, R.; Mingoia, F.; Terenzi, A.; Martorana, A.; Barone, G.; Almerico, A.M. 1,2,3-Triazole in Heterocyclic Compounds, Endowed with Biological Activity, through 1,3-Dipolar Cycloadditions. Eur. J. Org. Chem. 2014, 2014, 3289–3306. [Google Scholar] [CrossRef]
  12. Johansson, J.R.; Beke-Somfai, T.; Said Stalsmeden, A.; Kann, N. Ruthenium-Catalyzed Azide Alkyne Cycloaddition Reaction: Scope, Mechanism, and Applications. Chem. Rev. 2016, 116, 14726–14768. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Hein, J.E.; Fokin, V.V. Copper-catalyzed azide-alkyne cycloaddition (CuAAC) and beyond: New reactivity of copper(I) acetylides. Chem. Soc. Rev. 2010, 39, 1302–1315. [Google Scholar] [CrossRef] [PubMed]
  14. Emileh, A.; Duffy, C.; Holmes, A.P.; Rosemary Bastian, A.; Aneja, R.; Tuzer, F.; Rajagopal, S.; Li, H.; Abrams, C.F.; Chaiken, I.M. Covalent conjugation of a peptide triazole to HIV-1 gp120 enables intramolecular binding site occupancy. Biochemistry 2014, 53, 3403–3414. [Google Scholar] [CrossRef]
  15. Kuntala, N.; Telu, J.R.; Banothu, V.; Nallapati, S.B.; Anireddy, J.S.; Pal, S. Novel benzoxepine-1,2,3-triazole hybrids: Synthesis and pharmacological evaluation as potential antibacterial and anticancer agents. Med. Chem. Commun. 2015, 6, 1612–1619. [Google Scholar] [CrossRef]
  16. Duan, H.; Sengupta, S.; Petersen, J.L.; Akhmedov, N.G.; Shi, X. Triazole-Au(I) complexes: A new class of catalysts with improved thermal stability and reactivity for intermolecular alkyne hydroamination. J. Am. Chem. Soc. 2009, 131, 12100–12102. [Google Scholar] [CrossRef]
  17. Nandivada, H.; Jiang, X.; Lahann, J. Click Chemistry: Versatility and Control in the Hands of Materials Scientists. Adv. Mater. 2007, 19, 2197–2208. [Google Scholar] [CrossRef]
  18. Ashok, D.; Chiranjeevi, P.; Kumar, A.V.; Sarasija, M.; Krishna, V.S.; Sriram, D.; Balasubramanian, S. 1,2,3-Triazole-fused spirochromenes as potential anti-tubercular agents: Synthesis and biological evaluation. RSC Adv. 2018, 8, 16997–17007. [Google Scholar] [CrossRef] [Green Version]
  19. Azagarsamy, M.A.; Anseth, K.S. Bioorthogonal Click Chemistry: An Indispensable Tool to Create Multifaceted Cell Culture Scaffolds. ACS Macro Lett. 2013, 2, 5–9. [Google Scholar] [CrossRef]
  20. Johnson, J.A.; Finn, M.G.; Koberstein, J.T.; Turro, N.J. Construction of Linear Polymers, Dendrimers, Networks, and Other Polymeric Architectures by Copper-Catalyzed Azide-Alkyne Cycloaddition “Click” Chemistry. Macromol. Rapid Commun. 2008, 29, 1052–1072. [Google Scholar] [CrossRef]
  21. Wang, S.; Zhang, Y.; Liu, G.; Xu, H.; Song, L.; Chen, J.; Li, J.; Zhang, Z. Transition-metal-free synthesis of 5-amino-1,2,3-triazoles via nucleophilic addition/cyclization of carbodiimides with diazo compounds. Org. Chem. Front. 2021, 8, 599–604. [Google Scholar] [CrossRef]
  22. Ferrini, S.; Chandanshive, J.Z.; Lena, S.; Comes Franchini, M.; Giannini, G.; Tafi, A.; Taddei, M. Ruthenium-catalyzed synthesis of 5-amino-1,2,3-triazole-4-carboxylates for triazole-based scaffolds: Beyond the dimroth rearrangement. J. Org. Chem. 2015, 80, 2562–2572. [Google Scholar] [CrossRef] [PubMed]
  23. Dorokhov, V.A.; Komkov, A.V. Addition of acetylacetone and ethyl acetoacetate to carbodiimides promoted by nickel acetylacetonate. Russ. Chem. Bull. 2004, 53, 676–680. [Google Scholar] [CrossRef]
  24. Zhao, X.; Lu, B.W.; Lu, J.R.; Xin, C.W.; Li, J.F.; Liu, Y. Design, synthesis and antimicrobial activities of 1,2,3-triazole derivatives. Chin. Chem. Lett. 2012, 23, 933–935. [Google Scholar] [CrossRef]
  25. Lauria, A.; Abbate, I.; Patella, C.; Martorana, A.; Dattolo, G.; Almerico, A.M. New annelated thieno[2,3-e][1,2,3]triazolo[1,5-a]pyrimidines, with potent anticancer activity, designed through VLAK protocol. Eur. J. Med. Chem. 2013, 62, 416–424. [Google Scholar] [CrossRef]
  26. Liao, Y.; Lu, Q.; Chen, G.; Yu, Y.; Li, C.; Huang, X. Rhodium-Catalyzed Azide–Alkyne Cycloaddition of Internal Ynamides: Regioselective Assembly of 5-Amino-Triazoles under Mild Conditions. ACS Catal. 2017, 7, 7529–7534. [Google Scholar] [CrossRef]
  27. Dimroth, O. Ueber eine Synthese von Derivaten des 1,2,3-Triazols. Eur. J. Inorg. Chem. 1902, 35, 1029–1038. [Google Scholar]
  28. Dimroth, O. Ueber intramolekulare Umlagerungen. Umlagerungen in der Reihe des 1,2,3-Triazols. Justus Liebigs Ann. Chem. 1909, 364, 183–226. [Google Scholar] [CrossRef] [Green Version]
  29. Krishna, P.M.; Ramachary, D.B.; Peesapati, S. Azide–acetonitrile “click” reaction triggered by Cs2CO3: The atom-economic, high-yielding synthesis of 5-amino-1,2,3-triazoles. RSC Adv. 2015, 5, 62062–62066. [Google Scholar] [CrossRef]
  30. Lieber, E.; Chao, T.S.; Ramachandra Rao, C.N. Synthesis and Isomerization of Substituted 5-Amino-1,2,3-triazoles1. J. Org. Chem. 2002, 22, 654–662. [Google Scholar] [CrossRef]
  31. Cottrell, I.F.; Hands, D.; Houghton, P.G.; Humphrey, G.R.; Wright, S.H.B. An improved procedure for the preparation of 1-benzyl-1H-1,2,3-triazoles from benzyl azides. J. Heterocycl. Chem. 1991, 28, 301–304. [Google Scholar] [CrossRef]
  32. Pokhodylo, N.T.; Matiychuk, V.S.; Obushak, N.B. Synthesis of 1H-1,2,3-triazole derivatives by the cyclization of aryl azides with 2-benzothiazolylacetonone, 1,3-benzo-thiazol-2-ylacetonitrile, and (4-aryl-1,3-thiazol-2-yl)acetonitriles. Chem. Heterocycl. Compd. 2009, 45, 483–488. [Google Scholar] [CrossRef]
  33. Opsomer, T.; Thomas, J.; Dehaen, W. Chemoselectivity in the Synthesis of 1,2,3-Triazoles from Enolizable Ketones, Primary Alkylamines, and 4-Nitrophenyl Azide. Synthesis 2017, 49, 4191–4198. [Google Scholar]
  34. Navarro, Y.; Garcia Lopez, J.; Iglesias, M.J.; Lopez Ortiz, F. Chelation-Assisted Interrupted Copper(I)-Catalyzed Azide-Alkyne-Azide Domino Reactions: Synthesis of Fully Substituted 5-Triazenyl-1,2,3-triazoles. Org. Lett. 2021, 23, 334–339. [Google Scholar] [CrossRef] [PubMed]
  35. Du, W.; Huang, H.; Xiao, T.; Jiang, Y. Metal-Free, Visible-Light Promoted Intramolecular Azole C−H Bond Amination Using Catalytic Amount of I2: A Route to 1,2,3-Triazolo[1,5-a]quinazolin-5(4H)-ones. Adv. Synth. Catal. 2020, 362, 5124–5129. [Google Scholar] [CrossRef]
  36. Roughley, S.D.; Jordan, A.M. The medicinal chemist’s toolbox: An analysis of reactions used in the pursuit of drug candidates. J. Med. Chem. 2011, 54, 3451–3479. [Google Scholar] [CrossRef] [PubMed]
  37. Flick, A.C.; Ding, H.X.; Leverett, C.A.; Kyne, R.E., Jr.; Liu, K.K.; Fink, S.J.; O’Donnell, C.J. Synthetic Approaches to the New Drugs Approved During 2015. J. Med. Chem. 2017, 60, 6480–6515. [Google Scholar] [CrossRef] [PubMed]
  38. Corbet, J.P.; Mignani, G. Selected patented cross-coupling reaction technologies. Chem. Rev. 2006, 106, 2651–2710. [Google Scholar] [CrossRef]
  39. Heravi, M.M.; Kheilkordi, Z.; Zadsirjan, V.; Heydari, M.; Malmir, M. Buchwald-Hartwig reaction: An overview. J. Organomet. Chem. 2018, 861, 17–104. [Google Scholar] [CrossRef]
  40. Wambua, V.; Hirschi, J.S.; Vetticatt, M.J. Rapid Evaluation of the Mechanism of Buchwald-Hartwig Amination and Aldol Reactions Using Intramolecular (13)C Kinetic Isotope Effects. ACS Catal. 2021, 11, 60–67. [Google Scholar] [CrossRef]
  41. Liu, Y.-F.; Wang, C.-L.; Bai, Y.-J.; Han, N.; Jiao, J.-P.; Qi, X.-L. A Facile Total Synthesis of Imatinib Base and Its Analogues. Org. Process Res. Dev. 2008, 12, 490–495. [Google Scholar] [CrossRef]
  42. Tundel, R.E.; Anderson, K.W.; Buchwald, S.L. Expedited palladium-catalyzed amination of aryl nonaflates through the use of microwave-irradiation and soluble organic amine bases. J. Org. Chem. 2006, 71, 430–433. [Google Scholar] [CrossRef] [PubMed]
  43. Kumar, R.; Ramachandran, U.; Khanna, S.; Bharatam, P.V.; Raichur, S.; Chakrabarti, R. Synthesis, in vitro and in silico evaluation of l-tyrosine containing PPARalpha/gamma dual agonists. Bioorg. Med. Chem. 2007, 15, 1547–1555. [Google Scholar] [CrossRef]
  44. Reddy, M.; Anusha, G.; Reddy, P. Sterically enriched bulky 1,3-bis(N,N′-aralkyl)benzimidazolium based Pd-PEPPSI complexes for Buchwald–Hartwig amination reactions. New J. Chem. 2020, 44, 11694–11703. [Google Scholar] [CrossRef]
  45. Deng, Q.; Zhang, Y.; Zhu, H.; Tu, T. Robust Acenaphthoimidazolylidene Palladacycles: Highly Efficient Catalysts for the Amination of N-Heteroaryl Chlorides. Chem. Asian J. 2017, 12, 2364–2368. [Google Scholar] [CrossRef] [PubMed]
  46. Moss, T.; Addie, M.; Nowak, T.; Waring, M. Room-Temperature Palladium-Catalyzed Coupling of Heteroaryl Amines with Aryl or Heteroaryl Bromides. Synlett 2012, 2012, 285–289. [Google Scholar] [CrossRef]
  47. Gribanov, P.S.; Atoian, E.M.; Philippova, A.N.; Topchiy, M.A.; Asachenko, A.F.; Osipov, S.N. One-Pot Synthesis of 5-Amino-1,2,3-triazole Derivatives via Dipolar Azide−Nitrile Cycloaddition and Dimroth Rearrangement under Solvent-Free Conditions. Eur. J. Org. Chem. 2021, 2021, 1378–1384. [Google Scholar] [CrossRef]
  48. Gribanov, P.S.; Topchiy, M.A.; Karsakova, I.V.; Chesnokov, G.A.; Smirnov, A.Y.; Minaeva, L.I.; Asachenko, A.F.; Nechaev, M.S. General Method for the Synthesis of 1,4-Disubstituted 5-Halo-1,2,3-triazoles. Eur. J. Org. Chem. 2017, 2017, 5225–5230. [Google Scholar] [CrossRef]
  49. Topchiy, M.A.; Asachenko, A.F.; Nechaev, M.S. Solvent-Free Buchwald-Hartwig Reaction of Aryl and Heteroaryl Halides with Secondary Amines. Eur. J. Org. Chem. 2014, 2014, 3319–3322. [Google Scholar] [CrossRef]
  50. Topchiy, M.A.; Dzhevakov, P.B.; Rubina, M.S.; Morozov, O.S.; Asachenko, A.F.; Nechaev, M.S. Solvent-Free Buchwald-Hartwig (Hetero)arylation of Anilines, Diarylamines, and Dialkylamines Mediated by Expanded-Ring N-Heterocyclic Carbene Palladium Complexes. Eur. J. Org. Chem. 2016, 2016, 1908–1914. [Google Scholar] [CrossRef]
  51. Chesnokov, G.A.; Gribanov, P.S.; Topchiy, M.A.; Minaeva, L.I.; Asachenko, A.F.; Nechaev, M.S.; Bermesheva, E.V.; Bermeshev, M.V. Solvent-free Buchwald–Hartwig amination with low palladium loadings. Mendeleev Commun. 2017, 27, 618–620. [Google Scholar] [CrossRef]
  52. Ageshina, A.A.; Sterligov, G.K.; Rzhevskiy, S.A.; Topchiy, M.A.; Chesnokov, G.A.; Gribanov, P.S.; Melnikova, E.K.; Nechaev, M.S.; Asachenko, A.F.; Bermeshev, M.V. Mixed er-NHC/phosphine Pd(ii) complexes and their catalytic activity in the Buchwald-Hartwig reaction under solvent-free conditions. Dalton. Trans. 2019, 48, 3447–3452. [Google Scholar] [CrossRef] [PubMed]
  53. Gribanov, P.S.; Chesnokov, G.A.; Dzhevakov, P.B.; Kirilenko, N.Y.; Rzhevskiy, S.A.; Ageshina, A.A.; Topchiy, M.A.; Bermeshev, M.V.; Asachenko, A.F.; Nechaev, M.S. Solvent-free Suzuki and Stille cross-coupling reactions of 4- and 5-halo-1,2,3-triazoles. Mendeleev Commun. 2019, 29, 147–149. [Google Scholar] [CrossRef]
  54. Gribanov, P.S.; Chesnokov, G.A.; Topchiy, M.A.; Asachenko, A.F.; Nechaev, M.S. A general method of Suzuki-Miyaura cross-coupling of 4- and 5-halo-1,2,3-triazoles in water. Org. Biomol. Chem. 2017, 15, 9575–9578. [Google Scholar] [CrossRef] [PubMed]
  55. Charles, M.D.; Schultz, P.; Buchwald, S.L. Efficient pd-catalyzed amination of heteroaryl halides. Org. Lett. 2005, 7, 3965–3968. [Google Scholar] [CrossRef] [PubMed]
  56. Afanas’ev, O.I.; Tsyplenkova, O.A.; Seliverstov, M.Y.; Sosonyuk, S.E.; Proskurnina, M.V.; Zefirov, N.S. Homocoupling of bromotriazole derivatives on metal complex catalysts. Russ. Chem. Bull. 2016, 64, 1470–1472. [Google Scholar] [CrossRef]
  57. Kolychev, E.L.; Asachenko, A.F.; Dzhevakov, P.B.; Bush, A.A.; Shuntikov, V.V.; Khrustalev, V.N.; Nechaev, M.S. Expanded ring diaminocarbene palladium complexes: Synthesis, structure, and Suzuki-Miyaura cross-coupling of heteroaryl chlorides in water. Dalton. Trans. 2013, 42, 6859–6866. [Google Scholar] [CrossRef]
  58. Farmer, J.L.; Pompeo, M.; Lough, A.J.; Organ, M.G. [(IPent)PdCl2(morpholine)]: A readily activated precatalyst for room-temperature, additive-free carbon-sulfur coupling. Chem. Eur. J. 2014, 20, 15790–15798. [Google Scholar] [CrossRef]
Molecules 27 01999 g001 550
Figure 1. Potential application of 5-amino-1,2,3-triazoles N-substituted derivatives.
Figure 1. Potential application of 5-amino-1,2,3-triazoles N-substituted derivatives.
Molecules 27 01999 g001
Molecules 27 01999 sch001 550
Scheme 1. 1,3-Dipolar cycloaddition reaction (DCR) between aryl azides and monosubstituted acetonitriles.
Scheme 1. 1,3-Dipolar cycloaddition reaction (DCR) between aryl azides and monosubstituted acetonitriles.
Molecules 27 01999 sch001
Molecules 27 01999 g002 550
Figure 2. Simplified catalytic cycle for Buchwald−Hartwig amination reaction.
Figure 2. Simplified catalytic cycle for Buchwald−Hartwig amination reaction.
Molecules 27 01999 g002
Molecules 27 01999 sch002 550
Scheme 2. Synthetic approach to 5-amino-1,2,3-triazoles (a), 5-halo-1,2,3-triazoles (b) and N-arylamino 1,2,3-triazoles (c).
Scheme 2. Synthetic approach to 5-amino-1,2,3-triazoles (a), 5-halo-1,2,3-triazoles (b) and N-arylamino 1,2,3-triazoles (c).
Molecules 27 01999 sch002
Molecules 27 01999 g003 550
Figure 3. Structures of (THP-Dipp) Pd complexes.
Figure 3. Structures of (THP-Dipp) Pd complexes.
Molecules 27 01999 g003
Molecules 27 01999 sch003 550
Scheme 3. Buchwald–Hartwig cross-coupling of 5-amino-1,2,3-triazoles 1. 1 Conditions: 5-amino-1,2,3-triazole (0.5 mmol); (het)aryl-Hal (1 equiv.); (THP-Dipp)Pd(cinn)Cl (2 mol %); t-BuONa (3 equiv.); 1,4-dioxane (2.5 mL); 120 °C under argon 24 h; 2 4,6-Dichloropyrimidine (0.25 mmol); 5-aminotriazole (2.0 equiv.); (THP-Dipp)Pd(cinn)Cl (4 mol %), t-BuONa (6 equiv.).
Scheme 3. Buchwald–Hartwig cross-coupling of 5-amino-1,2,3-triazoles 1. 1 Conditions: 5-amino-1,2,3-triazole (0.5 mmol); (het)aryl-Hal (1 equiv.); (THP-Dipp)Pd(cinn)Cl (2 mol %); t-BuONa (3 equiv.); 1,4-dioxane (2.5 mL); 120 °C under argon 24 h; 2 4,6-Dichloropyrimidine (0.25 mmol); 5-aminotriazole (2.0 equiv.); (THP-Dipp)Pd(cinn)Cl (4 mol %), t-BuONa (6 equiv.).
Molecules 27 01999 sch003
Molecules 27 01999 sch004 550
Scheme 4. Buchwald–Hartwig cross-coupling of 4- and 5-halo-1,2,3-triazoles 1. 1 Reaction conditions: 4- or 5-halo-1,2,3-triazole (0.5 mmol); aryl-NH2 (1 equiv.); (THP-Dipp)Pd(cinn)Cl (2 mol %); t-BuONa (3 equiv.); 1,4-dioxane (2.5 mL); 120 °C under argon, 24 h.
Scheme 4. Buchwald–Hartwig cross-coupling of 4- and 5-halo-1,2,3-triazoles 1. 1 Reaction conditions: 4- or 5-halo-1,2,3-triazole (0.5 mmol); aryl-NH2 (1 equiv.); (THP-Dipp)Pd(cinn)Cl (2 mol %); t-BuONa (3 equiv.); 1,4-dioxane (2.5 mL); 120 °C under argon, 24 h.
Molecules 27 01999 sch004
Table
Table 1. Screening of catalytic systems in the BHA reaction 1.
Table 1. Screening of catalytic systems in the BHA reaction 1.
Molecules 27 01999 i001
Entry[Pd] (mol.%)Base (Equiv.)Yield, %
1(THP-Dipp)Pd(cinn)Cl (1)t-BuONa (1.2)53
2(THP-Dipp)Pd(cinn)Cl (2)t-BuONa (1.2)86
3(THP-Dipp)Pd(cinn)Cl (2)t-BuONa (3.0)97
4(THP-Dipp)PdAllylCl (2)t-BuONa (1.2)73
5(THP-Dipp)PdMetallylCl (2)t-BuONa (1.2)39
6Pd(OAc)2 (2 mol %)/RuPhos (4)t-BuONa (1.2)30
7Pd(OAc)2 (2 mol %)/SPhos (4)t-BuONa (1.2)5
8Pd(OAc)2 (2 mol %)/DavePhos (4)t-BuONa (1.2)12
9Pd(OAc)2 (2 mol %)/XPhos (4)t-BuONa (1.2)6
10(THP-Dipp)Pd(cinn)Cl (2)Cs2CO3 (1.2)16
1 Reaction conditions:1-benzyl-4-phenyl-1H-1,2,3-triazol-5-amine 1a (0.5 mmol); 1-bromo-4-methylbenzene (1 equiv.); [Pd], base; 1,4-dioxane (2.5 mL); 120 °C, 24 h.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Gribanov, P.S.; Philippova, A.N.; Topchiy, M.A.; Minaeva, L.I.; Asachenko, A.F.; Osipov, S.N. General Method of Synthesis of 5-(Het)arylamino-1,2,3-triazoles via Buchwald–Hartwig Reaction of 5-Amino- or 5-Halo-1,2,3-triazoles. Molecules 2022, 27, 1999. https://doi.org/10.3390/molecules27061999

AMA Style

Gribanov PS, Philippova AN, Topchiy MA, Minaeva LI, Asachenko AF, Osipov SN. General Method of Synthesis of 5-(Het)arylamino-1,2,3-triazoles via Buchwald–Hartwig Reaction of 5-Amino- or 5-Halo-1,2,3-triazoles. Molecules. 2022; 27(6):1999. https://doi.org/10.3390/molecules27061999

Chicago/Turabian Style

Gribanov, Pavel S., Anna N. Philippova, Maxim A. Topchiy, Lidiya I. Minaeva, Andrey F. Asachenko, and Sergey N. Osipov. 2022. "General Method of Synthesis of 5-(Het)arylamino-1,2,3-triazoles via Buchwald–Hartwig Reaction of 5-Amino- or 5-Halo-1,2,3-triazoles" Molecules 27, no. 6: 1999. https://doi.org/10.3390/molecules27061999

Article Metrics

Back to TopTop